Like in NSCLC, BOK protein levels were again found to be significantly lower in tumor tissue compared to matched normal tissue, and higher BOK expression positively correlated with overall as well as with relapse-free survival of breast cancer patients (Onyeagucha et al., 2017). This evidence concerns the gene BOK and breast carcinoma.